跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Atosiban acetate
首页
药物
Atosiban acetate
Atosiban acetate
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
OXYTOCIN RECEPTOR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PREPARATION AND USE THEREOF
WO 2025232577 A1
申请人: NANJING LINGNUO BIOMEDICAL TECH RESEARCH INSTITUTE CO LTD
优先权: 2024
CN
WO
2 件公开
Method for preparing atosiban acetate
US 9434767 B2
申请人: XIAO QING
优先权: 2010
US
2 件公开
Method for synthesizing atosiban acetate from solid phase polypeptide
CN 101357937 B
申请人: SHANGHAI SOHO YIMING PHARMACEUTICALS CO LTD
优先权: 2007
CN
Atosiban acetate composition
CN 105920581 A
申请人: YANGTZE RIVER PHARMACEUTICAL GROUP GUANGZHOU HAIRUI PHARMACEUTICAL CO LTD
优先权: 2016
CN
Atosiban acetate impurities and preparation and detection methods
CN 105949283 A
申请人: HAINAN HERUI PHARMACEUTICAL CO LTD
优先权: 2016
CN
Atosiban acetate composition and preparation method thereof
CN 106267148 A
申请人: HAINAN HERUI PHARMACEUTICAL CO LTD
优先权: 2016
CN
Atosiban purification and separation method
CN 107312072 A
申请人: ZHEJIANG BAITAI BIOLOGY CO LTD
优先权: 2017
CN
Preparation method of atosiban acetate impurities
CN 110218242 A
申请人: HAINAN ZHONGHE PHARMACEUTICAL CO LTD
优先权: 2019
CN
Atosiban-containing pharmaceutical composition and preparation method thereof
CN 115040634 A
申请人: NANJING NUOSAIDE BIOTECHNOLOGY CO LTD
优先权: 2022
CN
Application and stabilization method of atosiban injection solution
CN 116173180 A
申请人: HAINAN ZHONGHE PHARMACEUTICAL CO LTD
优先权: 2023
CN
第 1 / 2 页
上一页
下一页
药物
反馈